BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gutin L, Yao F, Dodge JL, Grab J, Mehta N. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance. JAMA Netw Open 2019;2:e1910326. [PMID: 31469395 DOI: 10.1001/jamanetworkopen.2019.10326] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang NN, Zheng J, Wu Y, Lv JY, Zhang SW, Zhang YM, Jiang WT, Song TQ, Kim V, Tohme S, Liu T, Zhang W, Gu J, Wang ZY, Suo YH, Wang S, Li W, Zhang L, Xie Y, Zhou YH, Liu JY, Qiu YB, Shen ZY, Hao JH, Geller D, Lu W. Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation. Cancer Med 2022. [PMID: 36016484 DOI: 10.1002/cam4.5063] [Reference Citation Analysis]
2 Killian M, Mahony DO, Murphy K, Connor DO, Bird B, Murphy CG. Breast cancer outcomes in a private hospital appear better than national outcomes in a country with a mixed public/private healthcare model. Ir J Med Sci 2022. [PMID: 35415773 DOI: 10.1007/s11845-022-03003-z] [Reference Citation Analysis]
3 Flemming JA, Muaddi H, Djerboua M, Neves P, Sapisochin G, Selzner N. Association between social determinants of health and rates of liver transplantation in individuals with cirrhosis. Hepatology 2022. [PMID: 35313040 DOI: 10.1002/hep.32469] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yuan L, Hanlon CL, Terrault N, Alqahtani S, Tamim H, Lai M, Saberi B. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States. Am J Gastroenterol 2022;117:433-44. [PMID: 35083985 DOI: 10.14309/ajg.0000000000001591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Park C, Jones M, Kaplan S, Koller FL, Wilder JM, Boulware LE, Mcelroy LM. A scoping review of inequities in access to organ transplant in the United States. Int J Equity Health 2022;21. [DOI: 10.1186/s12939-021-01616-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
6 Sugumar K, Markt SC, Hue JJ, Hoehn RS, Lee RT, Chavin KD, Rothermel LD, Winter JM, Hardacre JM, Ammori JB, Ocuin LM. Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular carcinoma. HPB (Oxford) 2021:S1365-182X(21)01690-7. [PMID: 34872866 DOI: 10.1016/j.hpb.2021.10.023] [Reference Citation Analysis]
7 Huang DC, Fricker ZP, Alqahtani S, Tamim H, Saberi B, Bonder A. The influence of equitable access policies and socioeconomic factors on post-liver transplant survival. EClinicalMedicine 2021;41:101137. [PMID: 34585128 DOI: 10.1016/j.eclinm.2021.101137] [Reference Citation Analysis]
8 Núñez KG, Sandow T, Fort D, Patel J, Hibino M, Carmody I, Cohen AJ, Thevenot P. Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4765. [PMID: 34638251 DOI: 10.3390/cancers13194765] [Reference Citation Analysis]
9 Zheng Y, Zhang X, Lu J, Liu S, Qian Y. Association between socioeconomic status and survival in patients with hepatocellular carcinoma. Cancer Med 2021;10:7347-59. [PMID: 34414679 DOI: 10.1002/cam4.4223] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Bockorny B, Bullock AJ, Abrams TA, Faintuch S, Alsop DC, Goldberg SN, Ahmed M, Miksad RA. Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma. Dig Dis Sci 2021. [PMID: 34297268 DOI: 10.1007/s10620-021-07156-2] [Reference Citation Analysis]
11 Emamaullee JA, Aljehani M, Hogen RVT, Zhou K, Lee JSH, Sher LS, Genyk YS. Potential association between public medical insurance, waitlist mortality, and utilization of living donor liver transplantation: An analysis of the Scientific Registry of Transplant Recipients. Clin Transplant 2021. [PMID: 34236113 DOI: 10.1111/ctr.14418] [Reference Citation Analysis]
12 Wong RJ, Ahmed A; Hepatocellular Carcinoma Research Committee of the Chronic Liver Disease Foundation. Understanding Gaps in the Hepatocellular Carcinoma Cascade of Care: Opportunities to Improve Hepatocellular Carcinoma Outcomes.J Clin Gastroenterol. 2020;54:850-856. [PMID: 33030855 DOI: 10.1097/MCG.0000000000001422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nephew LD, Serper M. Racial, Gender, and Socioeconomic Disparities in Liver Transplantation. Liver Transpl 2021;27:900-12. [PMID: 33492795 DOI: 10.1002/lt.25996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wahid NA, Rosenblatt R, Brown RS Jr. A Review of the Current State of Liver Transplantation Disparities. Liver Transpl 2021;27:434-43. [PMID: 33615698 DOI: 10.1002/lt.25964] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
15 Warren C, Carpenter AM, Neal D, Andreoni K, Sarosi G, Zarrinpar A. Racial Disparity in Liver Transplantation Listing. J Am Coll Surg 2021;232:526-34. [PMID: 33444709 DOI: 10.1016/j.jamcollsurg.2020.12.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Karunungan KL, Sanaiha Y, Hernandez RA, Wilhalme H, Rudasill S, Hadaya J, DiNorcia J, Benharash P. Impact of Payer Status on Delisting Among Liver Transplant Candidates in the United States. Liver Transpl 2021;27:200-8. [PMID: 33185336 DOI: 10.1002/lt.25936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Alshuwaykh O, Kwong A, Goel A, Cheung A, Dhanasekaran R, Ahmed A, Daugherty T, Dronamraju D, Kumari R, Kim WR, Nguyen MH, Esquivel CO, Concepcion W, Melcher M, Bonham A, Pham T, Gallo A, Kwo PY. Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatol Commun 2021;5:516-25. [PMID: 33681683 DOI: 10.1002/hep4.1644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Robinson A, Hirode G, Wong RJ. Ethnicity and Insurance-Specific Disparities in the Model for End-Stage Liver Disease Score at Time of Liver Transplant Waitlist Registration and its Impact on Mortality. J Clin Exp Hepatol 2021;11:188-94. [PMID: 33746443 DOI: 10.1016/j.jceh.2020.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]